Positive predictive value was 60.3 percent, and specificity was 99.64 percent with MCED among adults aged 50 years and older.

Interim phase 3 IMAgINATION study data show monthly subcutaneous sefaxersen significantly reduces proteinuria (UPCR) at week 37 in adults with primary IgA nephropathy.

The national prevalence of any and heavy alcohol use in the United States has decreased since 2022, according to a research letter published online Sept. 22 i ...

Significant reduction in ultraprocessed food consumption seen with intervention, which was found to be acceptable.

Nutritional deficiencies are a common and underrecognized risk among pediatric patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment, according to a study published online ...

Peyronie disease trials attribute penile curvature improvements to injection therapies, but do not account for the placebo response.

The FDA has approved Gazyva (obinutuzumab) to reduce relapse risk in adult and pediatric patients aged 2 years and older with idiopathic nephrotic syndrome.

Clinically indistinguishable prognostic information seen for kidney and cardiovascular outcomes with UACR, UPCR.

A 67-year-old male patient initially presented with a PSA of 12. He ultimately underwent a prostate needle biopsy, with 3/8 ...

The Frame-to-Outcome (F2O) system analyzes surgical video to predict surgery patient recovery, another use case for AI in ...

A high genetic risk score was associated with an elevated risk for progression in patients with lower-risk cancers.

Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.